MBA MD - Surrozen Chief Officer
| SRZN Stock | USD 10.22 0.84 8.96% |
Insider
MBA MD is Chief Officer of Surrozen
| Age | 56 |
| Address | 171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 |
| Phone | 650 489 9000 |
| Web | https://www.surrozen.com |
Surrozen Management Efficiency
The company has return on total asset (ROA) of (0.3265) % which means that it has lost $0.3265 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.7359) %, meaning that it created substantial loss on money invested by shareholders. Surrozen's management efficiency ratios could be used to measure how well Surrozen manages its routine affairs as well as how well it operates its assets and liabilities. As of the 28th of November 2024, Return On Tangible Assets is likely to drop to -0.98. In addition to that, Return On Capital Employed is likely to drop to -1.23. At this time, Surrozen's Total Assets are very stable compared to the past year. As of the 28th of November 2024, Net Tangible Assets is likely to grow to about 132.5 M, while Non Current Assets Total are likely to drop about 4.7 M.Similar Executives
| Showing other executives | INSIDER Age | ||
| Jamie Moore | CytomX Therapeutics | N/A | |
| Jennifer Lachey | Keros Therapeutics | 51 | |
| PharmD Bigora | Processa Pharmaceuticals | 64 | |
| Ted Jenkins | Spero Therapeutics | N/A | |
| AO FRACP | Assembly Biosciences | 65 | |
| Uri MD | Assembly Biosciences | 52 | |
| PharmD Young | Processa Pharmaceuticals | 71 | |
| Jasbir Seehra | Keros Therapeutics | 68 | |
| Edith MD | Bolt Biotherapeutics | 67 | |
| Anne Moon | Tempest Therapeutics | N/A | |
| Keith MBA | Keros Therapeutics | 54 | |
| Ian Critchley | Spero Therapeutics | N/A | |
| Francis Conway | Larimar Therapeutics | N/A | |
| Nicole White | Assembly Biosciences | N/A | |
| Hoyoung MD | CytomX Therapeutics | 55 | |
| Karen Bergman | Bolt Biotherapeutics | N/A | |
| BCh BM | Kronos Bio | 40 | |
| Brian Varnum | Armata Pharmaceuticals | 64 | |
| Adam Zlotnick | Assembly Biosciences | N/A | |
| Simon MBBS | Keros Therapeutics | 54 | |
| John CPA | Unicycive Therapeutics | 62 | |
Management Performance
| Return On Equity | -1.74 | ||||
| Return On Asset | -0.33 |
Surrozen Leadership Team
Elected by the shareholders, the Surrozen's board of directors comprises two types of representatives: Surrozen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Surrozen. The board's role is to monitor Surrozen's management team and ensure that shareholders' interests are well served. Surrozen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Surrozen's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Charles Williams, Chief Officer | ||
| Roeland Nusse, CoFounder Advisor | ||
| Elizabeth Nguyen, VP Culture | ||
| MS JD, Gen Legal | ||
| Li Yang, Executive Research | ||
| WenChen MD, Chief Officer | ||
| Calvin MD, CoFounder Advisor | ||
| Esther Jhun, Controller | ||
| Christopher Garcia, CoFounder Advisor | ||
| MBA MD, Chief Officer | ||
| Craig MBA, President CEO |
Surrozen Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Surrozen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.74 | ||||
| Return On Asset | -0.33 | ||||
| Operating Margin | 0.12 % | ||||
| Current Valuation | 3.73 M | ||||
| Shares Outstanding | 3.25 M | ||||
| Shares Owned By Insiders | 1.60 % | ||||
| Shares Owned By Institutions | 77.18 % | ||||
| Number Of Shares Shorted | 23.71 K | ||||
| Price To Book | 5.86 X | ||||
| Price To Sales | 3.32 X |
Pair Trading with Surrozen
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Surrozen position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surrozen will appreciate offsetting losses from the drop in the long position's value.Moving against Surrozen Stock
| 0.62 | RGNX | Regenxbio | PairCorr |
| 0.44 | FDMT | 4D Molecular Therapeutics | PairCorr |
| 0.32 | NKTX | Nkarta Inc Buyout Trend | PairCorr |
| 0.31 | INKT | Mink Therapeutics | PairCorr |
The ability to find closely correlated positions to Surrozen could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Surrozen when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Surrozen - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Surrozen to buy it.
The correlation of Surrozen is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Surrozen moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Surrozen moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Surrozen can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Surrozen. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. To learn how to invest in Surrozen Stock, please use our How to Invest in Surrozen guide.You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Surrozen. If investors know Surrozen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Surrozen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (16.94) | Revenue Per Share 3.804 | Return On Assets (0.33) | Return On Equity (1.74) |
The market value of Surrozen is measured differently than its book value, which is the value of Surrozen that is recorded on the company's balance sheet. Investors also form their own opinion of Surrozen's value that differs from its market value or its book value, called intrinsic value, which is Surrozen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Surrozen's market value can be influenced by many factors that don't directly affect Surrozen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Surrozen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Surrozen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Surrozen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.